17 Mar Launch of mobile processing laboratories to detect COVID-19

Posted at 07:00h in Board, Novacyt Group, Products by

Paris, France and Camberley, UK – 17 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the expansion of its VersaLab™ service with the launch of mobile processing laboratories (MPL) to provide rapid turnaround polymerase chain reaction (PCR) testing on-site. Testing will be performed using mid-nose nasal swabs, which were found to be effective and well tolerated compared to the more invasive nasopharyngeal swabs in the interim review of Queen Mary University of London’s clinical trial in care homes, as announced by the Company on 16 November 2020.

https://novacyt.com/wp-content/uploads/2021/03/Novacyt-Mobile-Lab-Testing-ENGLISH-17.03.2021-1.pdf